TrialCancer2013

The effect of prior androgen synthesis inhibition on outcomes of subsequent therapy with docetaxel in patients with metastatic castrate-resistant prostate cancer: results from a retrospective analysis of a randomized phase 3 clinical trial (CALGB 90401) (Alliance).

Rahul Aggarwal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.